Richard Dana Ono

Managing Director, Life Sciences at VIMAC Ventures LLC

Richard Dana Ono

Richard Dana Ono

Managing Director, Life Sciences at VIMAC Ventures LLC

Overview
Career Highlights

IntraImmune Therapies, Inc.
VIMAC Milestone Medica Fund LP

RelSci Relationships

530

Number of Boards

7

Birthday

1953

Age

67

Relationships
RelSci Relationships are individuals Richard Dana Ono likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at Massachusetts Biotechnology Council

Relationship likelihood: Strong

President & Chief Executive Officer at Massachusetts Biotechnology Council

Relationship likelihood: Strong

Chairman of the Board, President & Chief Executive Officer at Lipocine, Inc.

Relationship likelihood: Strong

Chief Executive Officer at Aciont, Inc.

Relationship likelihood: Strong

Managing Director at Gambel Oaks Advisors LLC

Relationship likelihood: Strong

Limited Partner at VIMAC Ventures LLC

Relationship likelihood: Strong

Interim Chief Executive Officer at Kalgene Pharmaceuticals, Inc.

Relationship likelihood: Strong

Chief Operating Officer at Bensussen Deutsch & Associates LLC

Relationship likelihood: Strong

President & Executive Vice President-Research & Development at Xilio Therapeutics, Inc.

Relationship likelihood: Strong

Chief Executive Officer & Co-Founder at AOBiome LLC

Relationship likelihood: Strong

Paths to Richard Dana Ono
Potential Connections via
Relationship Science
You
Richard Dana Ono
Managing Director, Life Sciences at VIMAC Ventures LLC
Education
A.B., Earth & Planetary Sciences

To educate students, to foster independent & original research, and to share benefits discovered.

Graduate

The oldest corporation in the Western Hemisphere is the Harvard Corporation, known formally as the President and Fellows of Harvard College. It is the smaller of Harvard’s two governing boards; the other is the Board of Overseers. Following are the members of the Harvard Corporation.

Memberships
Member
Current

The MBL is an international center for research, education, and training in biology, biomedicine, and environmental science. The oldest private marine laboratory in the country, the MBL has a year-round staff of more than 270 scientists and support personnel working in such fields as cell, developmental, and regenerative biology, ecology, microbiology, genetics and metagenomics, neurobiology, sensory biology, and biodiversity informatics. Each summer, an additional 1,700 scientists and advanced students from around the world come to the MBL to study and conduct research. The MBL’s educational program, which offers seven major summer courses and approximately twenty special topics courses throughout the year, plays a significant role in training the world's biologists and environmental scientists

Member
Current

The Explorers Club is an international multidisciplinary professional society dedicated to the advancement of field research and the ideal that it is vital to preserve the instinct to explore. Since its inception in 1904, the Club has served as a meeting point and unifying force for explorers and scientists worldwide.

Career History
Managing Director, Life Sciences
Current

VIMAC Ventures invests primarily in emerging growth companies located in the northeastern region of the US and in Canada. The firm focuses on early-stage ventures in information technology, advanced materials technologies and the other focused on life sciences. They target companies that are generating business innovations in information technology, communications and Internet technologies. Their life sciences investments focus on early-stage biotechnology and medical device companies. Investments typically range from $5 million to $15 million. VIMAC Ventures leads or co-leads most of their investments.

President & Chief Executive Officer
1995 - 2000

IntraImmune Therapies, Inc., a subsidiary of Amgen, Inc., is a company headquartered in Cambridge, MA. The firm develops technologies that allow antibodies to gain access to intracellular targets. It was founded by Richard Dana Ono. Abgenix, Inc. acquired IntraImmune Therapies, Inc. on 14 Nov 00 for $9 million.

Co-Founder & Managing Director
Prior

VIMAC Milestone Medica Fund LP invests in life science and healthcare companies located in the Eastern US and Canada. The fund targets companies operating in the fields of pharmaceuticals, biotechnology & medical device and cutting-edge products. It provides financing for early and later stage capital requirements with an initial investment size of $2 - $3 million and invests up to $5 - $7 million per company. It acts as a lead investor.

Boards & Committees
Independent Director
2014 - Current

Inhibitor Therapeutics, Inc. engages in the discovery, development, and commercialization of therapeutics for patients with cancer. It focuses on SUBA-Itraconazole, a patented, oral formulation of Itraconazole, for treatment of prostate and lung cancers. The company was founded on September 30, 1992 and is headquartered in Tampa, FL.

Independent Director
2014 - Current

Lipocine, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development for the delivery of drugs using proprietary delivery technology. The firm involves in applying oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. It offers TLANDO, an oral testosterone replacement therapy. The company was founded in 2011 and is headquartered in Salt Lake City, UT.

Director
Prior

Mimetogen Pharmaceuticals, Inc. develops peptidomimetic small molecule drugs against glaucoma and cancer. Its product mimic the effects of neurotrophin proteins that help to maintain the health and growth of cells and tissues found in the eye. Mimetogen provides tyrosine kinase agonists that prevent neuronal death; small molecule tyrosine kinase receptor agonists, which stimulates mucin secretion from conunctival goblet cells; and small molecule neurotrophin mimetics that rescues retinal pigment epithelial cells from oxidative stress-induced apoptosis. The company was founded by Garth Cumberlidge and H. Uri Saragovi in 2005 and is headquartered in Montreal, Canada.

Founding Director
Current

MASSBIO IS COMMITTED TO ADVANCING MASSACHUSETTS' LEADERSHIP IN THE LIFE SCIENCES TO GROW THE INDUSTRY, ADD VALUE TO THE HEALTH CARE SYSTEM AND IMPROVE PATIENT LIVES.

Member, Development Committee
Prior

The MBL is an international center for research, education, and training in biology, biomedicine, and environmental science. The oldest private marine laboratory in the country, the MBL has a year-round staff of more than 270 scientists and support personnel working in such fields as cell, developmental, and regenerative biology, ecology, microbiology, genetics and metagenomics, neurobiology, sensory biology, and biodiversity informatics. Each summer, an additional 1,700 scientists and advanced students from around the world come to the MBL to study and conduct research. The MBL’s educational program, which offers seven major summer courses and approximately twenty special topics courses throughout the year, plays a significant role in training the world's biologists and environmental scientists

Member, Board of Directors
Prior

Ocean Conservancy, Inc. engages in the provision of wildlife services. The firm protects the ocean from global challenges. It creates science based solutions for a healthy ocean and the wildlife and communities that depend on it. The company was founded in 1972 and is headquartered in Washington, DC.

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Richard Dana Ono. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Richard Dana Ono's profile does not indicate a business or promotional relationship of any kind between RelSci and Richard Dana Ono.